Catalogo dei prodotti della ricerca

SANTORO, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.176
EU - Europa 2.007
AS - Asia 1.219
SA - Sud America 88
AF - Africa 30
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.530
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.113
IT - Italia 586
SG - Singapore 573
SE - Svezia 518
IN - India 352
CN - Cina 235
RU - Federazione Russa 171
DE - Germania 150
FI - Finlandia 105
UA - Ucraina 97
RO - Romania 78
BR - Brasile 57
BG - Bulgaria 55
CA - Canada 50
GB - Regno Unito 44
AT - Austria 43
BE - Belgio 38
IE - Irlanda 36
NL - Olanda 31
AR - Argentina 22
FR - Francia 11
MX - Messico 10
ZA - Sudafrica 10
ID - Indonesia 9
TG - Togo 9
CH - Svizzera 8
JP - Giappone 7
HK - Hong Kong 6
IR - Iran 6
IL - Israele 5
LT - Lituania 5
VN - Vietnam 5
AU - Australia 4
CL - Cile 4
LV - Lettonia 4
SC - Seychelles 4
DK - Danimarca 3
EG - Egitto 3
ES - Italia 3
EU - Europa 3
GR - Grecia 3
HR - Croazia 3
NZ - Nuova Zelanda 3
PE - Perù 3
PK - Pakistan 3
PL - Polonia 3
TR - Turchia 3
BA - Bosnia-Erzegovina 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
JO - Giordania 2
LK - Sri Lanka 2
MA - Marocco 2
MT - Malta 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
CO - Colombia 1
CY - Cipro 1
EC - Ecuador 1
IS - Islanda 1
KE - Kenya 1
KR - Corea 1
KW - Kuwait 1
MY - Malesia 1
NI - Nicaragua 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
Totale 8.530
Salva come PNG Salva come JPEG
Città #
Fairfield 757
Singapore 405
Ashburn 393
Chandler 372
Woodbridge 343
Seattle 288
Houston 281
Cambridge 268
Wilmington 264
San Paolo di Civitate 218
Princeton 210
Plano 182
Rome 175
Santa Clara 164
Millbury 155
Beijing 153
Ann Arbor 137
Lawrence 125
San Diego 66
Norwalk 57
Andover 55
Boston 55
Sofia 55
Des Moines 42
Brussels 38
Moscow 35
Dublin 34
Falkenstein 33
Jacksonville 31
Toronto 30
Vienna 29
Dearborn 27
New York 24
Bremen 21
San Mateo 20
Yubileyny 20
Helsinki 19
Federal 18
Mannheim 17
Nuremberg 17
Bühl 13
Ottawa 12
Southend 12
Los Angeles 11
Buffalo 10
Nanjing 10
Naples 10
Boardman 9
Florence 9
Jakarta 9
Lomé 9
Muizenberg 8
Trento 8
Amsterdam 7
Bologna 7
Frankfurt am Main 7
Catania 6
Hefei 6
Kunming 6
London 6
Milan 6
Council Bluffs 5
Hong Kong 5
Redmond 5
Redwood City 5
Stockholm 5
São Paulo 5
Tokyo 5
Bern 4
Guangzhou 4
Ho Chi Minh City 4
Provo 4
Richardson 4
Riga 4
Zurich 4
Bari 3
Camerino 3
Chicago 3
Falls Church 3
Fremont 3
Hanover 3
Jinan 3
New Haven 3
Newark 3
Nürnberg 3
Poggiomarino 3
Prineville 3
Rio de Janeiro 3
Sirmione 3
Amman 2
Ansbach 2
Arnsberg 2
Auckland 2
Baraq 2
Bedizzole 2
Belo Horizonte 2
Boulder 2
Bratislava 2
Brooklyn 2
Cairo 2
Totale 5.941
Salva come PNG Salva come JPEG
Nome #
(Auto)Antibody Responses Shape Memory NK Cell Pool Size and Composition 122
Efficacy of rituximab treatment in postpartum acquired haemophilia A. 106
Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma 103
Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey 87
Maternal thrombophilia and adverse pregnancy outcome: a case-control study 85
Use of edoxaban for the treatment of venous thromboembolism in HIV-infected patients 83
Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: An index of different clinical severity of the 2 coagulation disorders 82
Increased von willebrand factor platelet-binding capacity is related to poor prognosis in Covid-19 patients 77
Mortality and causes of death in Italian persons with haemophilia, 1990-2007 74
Direct oral anticoagulants in patients affected by major congenital thrombophilia 72
Antithrombin concentrate during pregnancy in congenital antithrombin deficiency: A single-center experience 70
Thrombosis and survival in essential thrombocythemia: A regional study of 1,144 patients 69
Emerging issues on comprehensive hemophilia care: preventing, identifying, and monitoring age-related comorbidities. 69
Effects of secondary prophylaxis started in adolescent and adult haemophiliacs 69
Acquired FXIII deficiency and AL amyloidosis: A case of a rare association 69
Haemostasis prophylaxis using single dose desmopressin acetate and extended use epsilon aminocaproic acid for adenotonsillectomy in patients with type 1 von Willebrand disease. 68
Application of the International Prognostic Score of Thrombosis for Essential Thrombocytemia(ET) (IPSET-Thrombosis) in a Cohort of ET Patients: Experience from Gruppo Laziale for Myeloproliferative Ph Negative Neoplasms 67
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia. 67
Are ET and PV Patients Two Similar Populations As Concern Thrombotic Risk Factors? 66
Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case. 66
Forum on: The role of recombinant factor VIII in children with severe haemophilia A 64
A long-term study of young patients with essential Thrombocythemia treated with anagrelide. 63
Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers. 63
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). 62
Rituximab in Previously Treated Primary Immune Thrombocytopenia Patients: Evaluation of Short- and Long-Term Efficacy and Safety. 62
Performance of recalibrated refacto laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one-stage assays after infusion of recalibrated refacto (B-domain deleted recombinant factor VIII) 61
A Case Of Thrombosis In Congenital Afibrinogenemia: A Physiopathologic And Management Dilemma 60
Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: effects of enzyme replacement therapy (ERT). 60
Prevalence of allo-immunization anti-HLA and anti-integrin alpha IIb beta 3 in Glanzmann thromboasthenia patients 59
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: Incidence, risk factors, and effect of treatments 59
Health-Related Quality of Life in Patients with Primary Immune Thrombocytopenia (pITP): Investigating Differences Amongst Newly Diagnosed, Persistent and Chronic Pitp Patients 59
Germ-line origin of intron 1 inversion in two haemophilia A families 57
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis 57
Incidence of Early Thrombosis in Myeloproliferative Neoplasms (MPN): A Prospective Analysis from the Gruppo Laziale of Ph-Negative MPN 57
Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy 57
Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential thrombocythemia: long-term results 56
Remission of acquired von Willebrand syndrome after successful treatment of gastric MALT lymphoma. 56
Secondary prophylaxis in a cohort of adolescent and adult Italian hemophiliacs 56
Decisional flow with a score system to start platelet-lowering treatment in patients with essential thrombocythemia (ET): Long-term results 56
Anagrelide treatment and cardiovascular evaluation in 130 patients with essential thrombocythemia (ET): Preliminary report of the Registro Italiano Trombocitemia (RIT). 55
Application of Global Coagulation Assays in Hemophilia B Patients to Evaluate the Hemostatic Potential in Baseline Conditions 55
Understanding inhibitor development in haemophilia A: Towards clinical prediction and prevention strategies 55
Efficacy and safety of antithrombotic prophylactic therapy with low-molecular weight heparin (LMWH) after orthopedic surgery in hemophilia patients 54
Tailored versus standard dose prophylaxis in children with hemophilia A. 54
Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. 54
Risultati di uno studio randomizzato con prednisone a basse o alte dosi in bambini e adolescenti con porpora trombocitopenia idiopatica (PTI). [RESULTS OF A RANDOMIZED TRIAL WITH PREDNISONE AT LOW OR HIGH DOSES IN CHILDREN AND ADOLESCENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA] 54
Application of global coagulation assays in Hemophilia B patients to evaluate the hemostatic potential in baseline conditions and after FIX concentrate administration 54
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy. 53
Successful hip arthroplasty in an adult male with severe factor XI deficiency using HEMOLEVEN (R), a factor XI concentrate 53
Thrombosis History and Relationship with Low Thrombocytosis, Leukocytosis, and Jak2 V617F Mutation In A Cohort of 977 Patients with Essential Thrombocythemia (ET): Preliminary Report of the Registro Italiano Trombocitemia(RIT) 52
Application of global coagulation assays in hemophilia B patients to evaluate the hemostatic potential in baseline conditions and after FIX concentrate administration 52
PICC-related upper deep venous thrombosis in patients with hematological malignancies. Management of anticoagulant therapy according to the platelet count 52
Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: Results of a retrospective study from a single centre 51
Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation 51
null 51
Successful hip arthroplasty in an adult male with severe factor XI deficiency using Hemoleven®, a factor XI concentrate. 51
A case of thrombosis in congenital afibrinogenemia patient: a physiopathologic and management dilemma 50
Essential Thrombocythemia: A Comparison of Overall and Thrombosis Free Survival in Two Discrete Periods of the First Decade of 2000. a Retrospective Analysis 50
null 50
null 50
Health-related quality of life and psychological well-being in elderly patients with haemophilia. 50
null 49
null 49
Idiopathic thrombocytopenic purpura (ITP) in the elderly: clinical course in 178 patients. 49
null 49
Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors. 48
Retrospective Evaluation of Phenotype and Management of A-hypo-dys-Fibrinogenemia in a Cohort of Italian Patients 48
null 48
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) 47
null 47
A Multicenter Real-Life Study On Anticoagulant Treatment With Direct Oral Anticoagulants In Patients With Ph Negative Myeloproliferative Neoplasms 47
null 46
Health Status of Elderly Persons with Hemophilia Compared with the General Population: The Sphera Study 46
null 46
null 46
Congenital FXI deficiency: evaluation of bleeding phenotype and correlation with FXI activity (FXI:Act) 46
Acquired haemophilia A (AHA): clinical features and management of patients from a single center. 45
null 45
Investigation of Possible Correlation Between Clinical and Laboratory Phenotype in Congenital FXI Deficiency: Results from a Single Center 45
null 45
null 45
null 44
Right elbow arthropathy in a patient with severe haemophilia A 44
Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy 44
How the Real-Life Diagnostic and Therapeutic Approach Changed in the Last Two Decades in the Thrombocythemic Patients with Ph-Negative Myeloproliferative Neoplasm. Report on 2388 Subjects of the Registro Italiano Trombocitemie (RIT) 43
BLEEDING RISK OF SURGERY IN PATIENTS WITH INHERITED PLATELET FUNCTION DISORDERS (IPFD): OUTCOME OF 389 SURGERIES IN 205 PATIENTS 43
null 43
null 43
DECISIONAL FLOW WITH A SCORE SYSTEM TO START PLATELET-LOWERING TREATMENT IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET): LONG-TERM RESULTS 42
Investigation of possible correlation between clinical and laboratory phenotype in congenital FXI deficiency: results from a single center 42
Retrospective evaluation of dysfibrinogenaemic patients in a single centre: clinical features and laboratory findings 42
null 42
RETROSPECTIVE EVALUATION OF PHENOTYPE AND MANAGEMENT OF DYSFIBRINOGENEMIA AND HYPODYSFIBRINOGENEMIA IN A COHORT OF ITALIAN PATIENTS 42
Single centre experience on Acquired Haemophilia A patients: Diagnosis, clinical management and analysis of factors predictive of response and outcome 42
Clinical and Biological Features in Patients with Ph-Negative Chronic Myeloproliferative Neoplasm Showing Different Molecular Pattern. Comparative Study in 596 Patients of the Registro Italiano Trombocitemie (RIT) 41
null 40
The Platelet COUNT at Diagnosis of Essential Thrombocythemia Is a Prognostic Factor for Thrombosis-Free Survival: Retrospective Analysis on 1201 Patients 40
SPLEEN ENLARGEMENT IS A RISK FACTOR FOR THROMBOSIS IN ESSENTIAL THROMBOCYTHEMIA: EVALUATION ON 1097 PATIENTS AND VALIDATION ON 792 PATIENTS 40
Dental invasive procedures in von Willebrand disease outpatients treated with high purity FVIII/VWF complex concentrate (Fanhdi®): experience of a single center 40
null 40
Totale 5.579
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.874
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020503 0 0 0 0 0 0 0 0 190 153 103 57
2020/2021424 55 71 31 29 8 18 12 49 59 56 28 8
2021/20221.749 13 76 133 77 272 89 28 156 130 162 174 439
2022/20231.866 370 539 86 127 132 216 43 119 140 12 61 21
2023/2024730 67 101 24 48 69 85 13 26 3 106 80 108
2024/20251.225 49 242 89 113 183 156 202 130 61 0 0 0
Totale 8.889